Key facts
- Latent Labs’s last known valuation is $139.9M (Feb 2025).
- It has raised $49.0M; the latest was Early Stage VC ($39.9M) in Feb 2025.
- Notable investors include Sequoia Capital, 8VC, AWS Startups, SBXi, Jeff Dean — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Latent Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Latent Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Latent Labs
Developer of AI-driven generative models designed for programmable biology. The company's models capture the fundamentals of biology, enabling healthcare partners to create new antibodies, optimize existing enzymes, and advance genetic engineering, providing unprecedented control over molecular biology.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 21
- Website
- latentlabs.com/
- Ownership
- Privately Held (backing)
Latent Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Latent Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Latent Labs in its N-PORT filings yet. We sweep new filings monthly.